MEPACT is a therapy for the treatment of non-metastatic osteosarcoma in children, adolescants and young adults following tumor removal. Osteosarcoma is an often fatal disease that affects mainly children and young adults, with 1,200 new cases diagnosed every year. On March 6, European Commission approved MEPACT for marketing within the 27 European states as well as Iceland, Liechtenstein and Norway.
Takeda Pharmaceutical Acquires IDM Pharma
Takeda Pharmaceutical Company announced Monday that its subsidiary, Takeda America, would acquire IDM Pharma Inc, offering $2.64 per share in an all cash tender to be followed by a merger. the Takeda Oncology Company will have development responsibilities for IDM Pharma's primary asset, MEPACT(R) (Mifamurtide).
Subscribe to:
Post Comments (Atom)
Superhit News
-
US health regulator USFDA has issued a warning letter to German drug firm Fresenius Kabi AG for lapses at its drug manufacturing fac... -
Goods and Service Tax (GST) is high on the agenda for the new government and its rollout is a priority. GST will benefit the Indian pharma... -
Rib-X Pharmaceuticals, Inc. announced today the signature of an exclusive worldwide research collaboration agreement and option for license ...
-
Physiomics: Reports difficult trading but highlights growing interest from big pharmaceutical groupsPhysiomics ( LON:PYC ) said that trading conditions were difficult in the six months ended 31 December 2010, but it believes it is in a be...
-
Hindusthan National Glass and Industries Ltd is expected to finalize a strategic overseas acquisition in the pharmaceuticals space in the n...
-
The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey through a written reply in the Lok Sabha informed about th... -
India's Central Drugs Standard Control Organization (CDSCO) has suspended the manufacturing of eye drops at the Chennai-based firm after... -
The government is hoping to see the implementation of the track and trace system for domestic and export supply chain in another one y... -
Amylin Pharmaceuticals, Inc. AMLN +16.15% and Alkermes plc ALKS +4.61% today announced that the U.S. Food and Drug Administration (FDA) has ...
-
Diclofenac injection is a painkiller which is manufactured by Themis Medicare Ltd and marketed by Novartis India under the brand name ...
No comments:
Post a Comment